| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. | Director | Common Stock | 37,219 | $27,914 | $0.7500 | 30 Jun 2025 | Direct |
| AGILE THERAPEUTICS INC | Director | Common Stock | 2,066 | $1,756 | $0.8500 | 09 Jun 2022 | Direct |
| AGILE THERAPEUTICS INC | Director | Employee Stock Option (Right to Buy) | 807 | 09 Jun 2022 | Direct | ||
| Endo International plc | Executive VP, Global R&D | 2015 Stock Incentive Plan Restricted Stock Units (RSU) | 0 | 15 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MTVA | MetaVia Inc. | 30 Jun 2025 | 1 | $0 | 4 | Director | 01 Jul 2025, 16:02 |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 07 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 19:24 |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 01 Dec 2023 | 2 | $0 | 4 | Director | 04 Dec 2023, 17:12 |
| NRBO | NeuroBo Pharmaceuticals, Inc. | 01 Nov 2023 | 0 | $0 | 3 | Director | 02 Nov 2023, 16:39 |
| ENDPQ | Endo International plc | 15 Jul 2022 | 1 | $0 | 4 | Executive VP, Global R&D | 17 Aug 2022, 06:31 |
| AGRX | AGILE THERAPEUTICS INC | 09 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:45 |
| ENDPQ | Endo International plc | 24 Feb 2022 | 0 | $0 | 3 | Executive VP, Global R&D | 24 Feb 2022, 15:01 |
| AGRX | AGILE THERAPEUTICS INC | 08 Jun 2021 | 2 | $0 | 4 | Director | 10 Jun 2021, 19:08 |